Literature DB >> 32603419

Gene Expression Thresholds Derived From Short-term Exposures Identify Rat Liver Tumorigens.

Thomas Hill1,2, John Rooney1,2,3, Jaleh Abedini1,4, Hisham El-Masri1, Charles E Wood1, J Christopher Corton1.   

Abstract

Traditional methods for cancer risk assessment are resource-intensive, retrospective, and not feasible for the vast majority of environmental chemicals. In this study, we investigated whether quantitative genomic data from short-term studies may be used to set protective thresholds for potential tumorigenic effects. We hypothesized that gene expression biomarkers measuring activation of the key early events in established pathways for rodent liver cancer exhibit cross-chemical thresholds for tumorigenesis predictive for liver cancer risk. We defined biomarker thresholds for 6 major liver cancer pathways using training sets of chemicals with short-term genomic data (3-29 days of exposure) from the TG-GATES (n = 77 chemicals) and DrugMatrix (n = 86 chemicals) databases and then tested these thresholds within and between datasets. The 6 pathway biomarkers represented genotoxicity, cytotoxicity, and activation of xenobiotic, steroid, and lipid receptors (aryl hydrocarbon receptor, constitutive activated receptor, estrogen receptor, and peroxisome proliferator-activated receptor α). Thresholds were calculated as the maximum values derived from exposures without detectable liver tumor outcomes. We identified clear response values that were consistent across training and test sets. Thresholds derived from the TG-GATES training set were highly predictive (97%) in a test set of independent chemicals, whereas thresholds derived from the DrugMatrix study were 96%-97% predictive for the TG-GATES study. Threshold values derived from an abridged gene list (2/biomarker) also exhibited high predictive accuracy (91%-94%). These findings support the idea that early genomic changes can be used to establish threshold estimates or "molecular tipping points" that are predictive of later-life health outcomes. Published by Oxford University Press on behalf of the Society of Toxicology 2020. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  adverse outcome pathway; biomarkers; carcinogenicity; constitutive activated receptor; key event; liver cancer; molecular initiating event; peroxisome proliferator-activated receptor alpha; toxicogenomics; transcript profiling

Mesh:

Year:  2020        PMID: 32603419      PMCID: PMC7990321          DOI: 10.1093/toxsci/kfaa102

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  36 in total

Review 1.  An overview of values for the threshold of toxicological concern.

Authors:  E C Hennes
Journal:  Toxicol Lett       Date:  2012-03-30       Impact factor: 4.372

Review 2.  Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.

Authors:  Gerald T Ankley; Richard S Bennett; Russell J Erickson; Dale J Hoff; Michael W Hornung; Rodney D Johnson; David R Mount; John W Nichols; Christine L Russom; Patricia K Schmieder; Jose A Serrrano; Joseph E Tietge; Daniel L Villeneuve
Journal:  Environ Toxicol Chem       Date:  2010-03       Impact factor: 3.742

3.  A Set of Six Gene Expression Biomarkers Identify Rat Liver Tumorigens in Short-term Assays.

Authors:  J Christopher Corton; Thomas Hill; Jeffrey J Sutherland; James L Stevens; John Rooney
Journal:  Toxicol Sci       Date:  2020-09-01       Impact factor: 4.849

4.  Molecular target sequence similarity as a basis for species extrapolation to assess the ecological risk of chemicals with known modes of action.

Authors:  Carlie A Lalone; Daniel L Villeneuve; Lyle D Burgoon; Christine L Russom; Henry W Helgen; Jason P Berninger; Joseph E Tietge; Megan N Severson; Jenna E Cavallin; Gerald T Ankley
Journal:  Aquat Toxicol       Date:  2013-09-19       Impact factor: 4.964

5.  Developmental disruption of thyroid hormone: correlations with hearing dysfunction in rats.

Authors:  K M Crofton
Journal:  Risk Anal       Date:  2004-12       Impact factor: 4.000

6.  The use of evidence from high-throughput screening and transcriptomic data in human health risk assessments.

Authors:  Roman Mezencev; Ravi Subramaniam
Journal:  Toxicol Appl Pharmacol       Date:  2019-08-07       Impact factor: 4.219

Review 7.  Identification of potential endocrine disrupting chemicals using gene expression biomarkers.

Authors:  J Christopher Corton; Nicole C Kleinstreuer; Richard S Judson
Journal:  Toxicol Appl Pharmacol       Date:  2019-07-17       Impact factor: 4.219

8.  Neurodevelopment and Thyroid Hormone Synthesis Inhibition in the Rat: Quantitative Understanding Within the Adverse Outcome Pathway Framework.

Authors:  Iman Hassan; Hisham El-Masri; Patricia A Kosian; Jermaine Ford; Sigmund J Degitz; Mary E Gilbert
Journal:  Toxicol Sci       Date:  2017-11-01       Impact factor: 4.849

9.  Adverse outcome pathway-driven identification of rat liver tumorigens in short-term assays.

Authors:  John Rooney; Thomas Hill; Chunhua Qin; Frank D Sistare; J Christopher Corton
Journal:  Toxicol Appl Pharmacol       Date:  2018-07-23       Impact factor: 4.219

Review 10.  Mode of action human relevance (species concordance) framework: Evolution of the Bradford Hill considerations and comparative analysis of weight of evidence.

Authors:  M E Bette Meek; Christine M Palermo; Ammie N Bachman; Colin M North; R Jeffrey Lewis
Journal:  J Appl Toxicol       Date:  2014-02-10       Impact factor: 3.446

View more
  1 in total

1.  A Collaborative Initiative to Establish Genomic Biomarkers for Assessing Tumorigenic Potential to Reduce Reliance on Conventional Rodent Carcinogenicity Studies.

Authors:  J Christopher Corton; Constance A Mitchell; Scott Auerbach; Pierre Bushel; Heidrun Ellinger-Ziegelbauer; Patricia A Escobar; Roland Froetschl; Alison H Harrill; Kamin Johnson; James E Klaunig; Arun R Pandiri; Alexei A Podtelezhnikov; Julia E Rager; Keith Q Tanis; Jan Willem van der Laan; Alisa Vespa; Carole L Yauk; Syril D Pettit; Frank D Sistare
Journal:  Toxicol Sci       Date:  2022-06-28       Impact factor: 4.109

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.